Fiserv, Inc. (FI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	73,564	116,867	79,729	64,182	68,525	76,336
Market Cap Growth	9.62%	46.58%	24.22%	-6.34%	-10.23%	-2.90%
Enterprise Value	102,271	141,685	102,614	85,481	89,569	97,655
Last Close Price	135.33	205.42	132.84	101.07	103.79	113.86
PE Ratio	22.68	37.33	25.99	25.37	51.37	79.68
Forward PE	12.37	20.95	16.00	14.13	16.61	21.92
PS Ratio	3.61	5.71	4.18	3.62	4.22	5.14
PB Ratio	2.92	4.22	2.60	2.03	2.15	2.29
P/FCF Ratio	14.26	23.09	21.13	20.45	23.84	23.51
P/OCF Ratio	10.86	17.62	15.45	13.90	16.99	18.41
PEG Ratio	0.84	1.55	1.16	1.57	1.01	1.31
EV/Sales Ratio	4.84	6.93	5.37	4.82	5.52	6.58
EV/EBITDA Ratio	10.82	15.79	12.88	12.47	16.29	21.21
EV/EBIT Ratio	16.12	24.10	21.17	23.19	38.89	64.59
EV/FCF Ratio	19.83	27.99	27.19	27.23	31.17	30.08
Debt / Equity Ratio	1.15	0.93	0.78	0.70	0.69	0.64
Debt / EBITDA Ratio	3.08	2.79	2.93	3.15	3.88	4.43
Debt / FCF Ratio	5.76	5.06	6.33	7.06	7.65	6.55
Asset Turnover	0.24	0.24	0.22	0.22	0.22	0.20
Inventory Turnover	14.27	19.38	-	-	-	-
Quick Ratio	0.22	0.25	0.16	0.17	0.20	0.22
Current Ratio	1.09	1.06	1.04	1.04	1.03	1.04
Return on Equity (ROE)	12.46%	10.90%	10.04%	8.12%	4.30%	2.86%
Return on Assets (ROA)	4.53%	4.37%	3.47%	2.88%	1.91%	1.24%
Return on Capital (ROIC)	7.22%	6.81%	5.59%	4.28%	2.65%	1.69%
Return on Capital Employed (ROCE)	11.10%	10.70%	8.50%	6.40%	4.00%	2.60%
Earnings Yield	4.59%	2.68%	3.85%	3.94%	1.95%	1.26%
FCF Yield	7.01%	4.33%	4.73%	4.89%	4.19%	4.25%
Buyback Yield / Dilution	5.33%	5.49%	4.94%	3.53%	1.73%	-30.77%

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q